Safety and efficacy of omecamtiv mecarbil for heart failure: A systematic review and meta-analysis

AIM: To assess the safety and efficacy of omecamtiv mecarbil compared with placebo in heart failure (HF) patients. METHODS: We searched PubMed, Web of Science, Cochrane Library, and SCOPUS until August 15th, 2021. We included all randomized controlled studies comparing omecamtiv mecarbil with placeb...

Descripción completa

Detalles Bibliográficos
Autores principales: Alqatati, Fadel, Elbahnasawy, Mohammad, Bugazia, Seif, Ragab, Khaled Mohamed, Elsnhory, Ahmed Bostamy, Shehata, Mostafa, Elsayed, Sarah Makram, Fathy, Mustafa Ali, Nourelden, Anas Zakarya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243594/
https://www.ncbi.nlm.nih.gov/pubmed/35301008
http://dx.doi.org/10.1016/j.ihj.2022.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243594/
https://www.ncbi.nlm.nih.gov/pubmed/35301008
http://dx.doi.org/10.1016/j.ihj.2022.03.005

Ejemplares similares